Home » Acambis, Sanofi Pasteur to Collaborate on West Nile Vaccine
Acambis, Sanofi Pasteur to Collaborate on West Nile Vaccine
Acambis has signed an exclusive agreement with Sanofi Pasteur, the vaccines division of sanofi-aventis, for Acambis’ ChimeriVax-West Nile vaccine.
According to the agreement, Acambis will receive an upfront payment of $10 million and be eligible for pre- and postmarketing milestone payments of up to $70 million based on product approval and sales in the U.S. market.
Acambis said it will continue development activities, including the filing of a license application in the U.S.
Upcoming Events
-
07May
-
14May
-
30May